Absea Biotech

Why settle for just one antibody?

With our new Pick 5 Antibody Kit, you choose only what you need — no waste, just results.

🧪 Includes up to two free 100 μL secondaries, all at a single price.
💡 Found a match? Reorder and get 20% off.

👇 Check the next image to see how it works!

Publication Spotlight: Advanced imaging reveals KIF13B enrichment at retinal synaptic ribbons!

Suiwal et al. (IJMS, Saarland Univ.) use confocal/SR-SIM/EM & a new monoclonal antibody (by Absea) to map KIF13B at the photoreceptor ribbon.

👉 doi.org/10.3390/ijms...

#Neuroscience #VisionScience

Ahead of the @asbmb.bsky.social‬ Proteomic Meeting, we’re curious:
Which emerging MS proteomics application has proven toughest to turn into routine data in your hands?

• Single-cell proteomics
• Spatial proteomics
• DIA-based PTM profiling
• Abs quant prot biomarkers

Share your thoughts below!

☀️Last week, the Absea team swapped pipettes for padlocks in an escape room!

It took brainpower and laughter to crack the final puzzle.
We capped the night with dinner, appreciating how much fun solving problems together is.

Escaping takes a whole team—even for scientists.

More information 👉 www.asbmb.org/meetings-eve...

American Society for Biochemistry and Molecular Biology (@asbmb.bsky.social) ASBMB drives discovery forward in academic, industry and governmental sectors, helping to generate new scientific knowledge today that fuels tomorrow’s biotechnological and medical breakthroughs. www....

⏳ Last day to register for asbmb.bsky.social Proteomics, Aug 17–21 (Cambridge)!

Meet Absea’s CEO, SVP & scientists (booth, 2nd floor)
Dive into mass spec & antibody tech
Chat about your proteomics challenges

Proud to sponsor and eager to hear what you’re working on!

#Proteomics #LifeSciences

🚀 We're heading to Cambridge for the ASBMB Proteomics Meeting, Aug 17–21!

Proud sponsor of this year's event by asbmb.bsky.social

- Meet our CEO, SVP & scientists
- Visit our booth on the second floor
- Have a research challenge? Tell us!

👀 Special announcement soon.

#LifeSciences #Proteomics

Absea Absea Biotechnology Ltd. is an innovative biotechnology company specialising in the production of high quality protein and antibody reagents. Since its foundation in 2020, Absea has built a library of...

Biomol: www.biomol.com/absea/
Nordic Biosite: nordicbiosite.com/products?act...
Cambridge Bioscience: www.bioscience.co.uk/find/?search...
Sanbio: www.sanbio.nl/resources/su....
Lubioscience: www.lubio.ch/supplier/absea
szabo scandic: www.szabo-scandic.com/en/manufactu...

Big news! Absea Biotech’s antibody collection on Europa Biosite is now 13,714 strong(up from 7,726)! 🎉

More recombinant antibodies, lyophilized shipments, and fresh data sheets to boost your research.

Explore what’s new here 👇

#Proteomic #Research #Antibodies

Explore our full antibody portfolio and validation data here: www.absea.bio/product-anti...

Autophagy research is complex. Finding reliable antibodies shouldn’t be.

We provide rigorously validated monoclonal antibodies covering key autophagy proteins—designed to support your experiments with proven reliability.

Happy to share insights or answer questions! #Autophagy #Biotech

Uncovering protein glycosylation dynamics and heterogeneity using deep quantitative glycoprofiling (DQGlyco) - Nature Structural & Molecular Biology Here the authors present deep quantitative glycoprofiling (DQGlyco), a method that enables high-throughput analysis of protein glycosylation dynamics. Using DQGlyco, they link gut microbiome compositi...

Read more here: www.nature.com/articles/s41...
Published in @natsmb.nature.com. June 2025 issue.

In case you missed it:

DQGlyco, led by Mikhail @savitski-lab.bsky.social (@embl.org, Absea SAB) & Clément M. Potel (then @embl.org, now Absea), enables deep profiling of 177,000+ N-glycopeptides in mouse brain (25× more than before).
New insights into protein & microbiome interplay.

#Proteomics

Innate immunity relies on rapid, precise detection of pathogens & danger signals.

Absea’s validated antibodies cover TLRs, RIG-I, MDA5, NLRP3, cGAS-STING & more—reliable for WB, IP, IHC in infection, cancer & aging research.

Which innate pathway are you working on? Let’s connect!
#Immunology

☀️ Celebrating our first official summer after works!

Working together is part of our daily routine, but we couldn’t resist stepping out of the lab to enjoy the first “hints” of summer.

Catching up and recharging together fuels our innovation in protein engineering and proteomics!

Curious about our validated antibody series for Tau, pTau, SNCA, and β-amyloid?
Learn more: www.absea.bio

🧠 Still chasing reproducibility in neurobiology—especially with tricky proteins like Tau or β-amyloid.
We’re always refining our monoclonal antibodies to help researchers get clearer results.
What’s your best tip for reliable biomarker data?
#Neuroscience #Biomarkers

What does it take to expand access to the human proteome?

Today we explore how we’ve produced 14,000+ proteins to date, now supporting new directions in disease biology and biomarker research.

Check out our thread for details and let’s connect!
#Proteomics #Biotech

Explore our antibody portfolio: absea.bio

🧠 June is Brain & Alzheimer’s Awareness Month.
We are committed to supporting researchers with our trusted antibodies for Aβ40, Aβ42, and alpha-synuclein—enabling sensitive biomarker detection in Alzheimer’s and Parkinson’s studies!
👀Tau solutions coming soon.
#BrainAwarenessMonth #Neuroscience

❓ Which mass-spec application is most critical in your lab?

🔹 Protein interaction mapping?
🔹 Quantitative proteomics?
🔹 Biomarker discovery?
🔹 Structural proteomics?

Reply with your focus in the comments!
#MassSpec #Proteomics

🧬 Tumor immune evasion:
↓ MHC I (up to 60%)
PD-L1/CTLA-4
TGF-β/Tregs/MDSCs
Warburg/IDO1

⚠️ Only 20–30% of patients respond long-term to ICIs.

🔬 Absea antibodies target these escape routes.

➡️ Which mechanism are you tackling?

Learn more: www.absea.bio

#TumorImmunity #CancerResearch #Immunotherapy

That’s a wrap on #ASMS2025! 🙌

Thanks to everyone who visited Absea’s booth—your questions and ideas made it a great week.

Top 3 discussed tools: 15N-labeled proteins, MHC-targeting antibodies, IHC-validated antibodies.

Exciting 15N news on the horizon—stay tuned! 👀

#Proteomics #MassSpec

🚨 Final poster session at #ASMS2025 —your last chance to connect with Absea at Booth 821!

Discover high-throughput proteomics and validated antibodies, covering 70% of the human proteome for comprehensive discovery.

🎉 Prize winner revealed at noon—stay tuned! #MassSpec

Halfway through #ASMS2025!

Curious how our N-15 proteins or MHC solutions can fit your proteomics projects?

Visit Booth #821 to chat with our team, learn about our reagent tools, and join our 5-year anniversary prize draw.

We look forward seeing you here!! 🧬🎉
#Biotech #Lifesciences

🚀 We're heading to ASMS 2025!

Stop by Booth #821 to meet our leadership and explore innovations in #massspectrometry & #proteomics.
Connect with Tao Chen (CEO), Philip Lossl (SVP), Joy Zhou (Marketing Director).

We look forward to seeing you there!
#ASMS2025 #biotech

It's our 5th birthday at #ASMS2025 - and we want to give YOU a present. Celebrate with us at booth 821 to win the rainbow main price and many other cool stuff!